HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Klatskin's Tumor (Klatskin Tumor)

Adenocarcinoma of the common hepatic duct bifurcation. These tumors are generally small, sharply localized, and seldom metastasizing. G. Klatskin's original review of 13 cases was published in 1965. Once thought to be relatively uncommon, tumors of the bifurcation of the bile duct now appear to comprise more than one-half of all bile duct cancers. (From Holland et al., Cancer Medicine, 3d ed, p1457)
Also Known As:
Klatskin Tumor; Klatskins Tumor; Tumor, Klatskin's
Networked: 47 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Jaundice
3. Carcinoma (Carcinomatosis)
4. Pathologic Constriction (Stenosis)
5. Cholangiocarcinoma

Experts

1. Paul, Andreas: 2 articles (11/2010 - 09/2004)
2. Shen, Yan: 2 articles (08/2005 - 02/2005)
3. Zhang, Min: 2 articles (08/2005 - 02/2005)
4. Hu, Anbin: 1 article (07/2015)
5. Lin, Yueming: 1 article (07/2015)
6. Wang, Guodong: 1 article (07/2015)
7. Liu, Furong: 1 article (07/2015)
8. He, Xiaoshun: 1 article (07/2015)
9. Ma, Yi: 1 article (07/2015)
10. Zhu, Xiaofeng: 1 article (07/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Klatskin's Tumor:
1. BismuthIBA
2. Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
3. Primary sclerosing cholangitisIBA
4. Intrahepatic cholangiocarcinomaIBA
5. perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
6. tranilast (N 5')IBA
7. Matrix MetalloproteinasesIBA
8. PlasticsIBA
9. IridiumIBA
10. Factor IX (PTC)FDA LinkGeneric

Therapies and Procedures

1. Liver Transplantation
2. Adjuvant Radiotherapy
3. Stents
4. Laparotomy
5. Brachytherapy